Search hospitals > New York > Syracuse

State University of New York Upstate Medical University

Claim this profile
Syracuse, New York 13210
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Lymphoma
Conducts research for Lung Cancer
Conducts research for Tumors
1030 reported clinical trials
52 medical researchers
Photo of State University of New York Upstate Medical University in SyracusePhoto of State University of New York Upstate Medical University in SyracusePhoto of State University of New York Upstate Medical University in Syracuse

Summary

State University of New York Upstate Medical University is a medical facility located in Syracuse, New York. This center is recognized for care of Cancer, Leukemia, Lymphoma, Lung Cancer, Tumors and other specialties. State University of New York Upstate Medical University is involved with conducting 1,030 clinical trials across 925 conditions. There are 52 research doctors associated with this hospital, such as Philip M. Monteleone, Mary Cunningham, M.D., Stephen L. Graziano, and Michael D. Mix.

Area of expertise

1Cancer
Global Leader
State University of New York Upstate Medical University has run 136 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Leukemia
Global Leader
State University of New York Upstate Medical University has run 111 trials for Leukemia. Some of their research focus areas include:
Stage II
CD5 positive
Stage I

Top PIs

Clinical Trials running at State University of New York Upstate Medical University

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Lymphoma
Diffuse Large B-Cell Lymphoma
Prostate Cancer
Multiple Myeloma
Small Cell Lung Cancer
Tumors
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at State University of New York Upstate Medical University?
State University of New York Upstate Medical University is a medical facility located in Syracuse, New York. This center is recognized for care of Cancer, Leukemia, Lymphoma, Lung Cancer, Tumors and other specialties. State University of New York Upstate Medical University is involved with conducting 1,030 clinical trials across 925 conditions. There are 52 research doctors associated with this hospital, such as Philip M. Monteleone, Mary Cunningham, M.D., Stephen L. Graziano, and Michael D. Mix.
Where is State University of New York Upstate Medical University located?
**State University of New York Upstate Medical University Hospital** - **Location:** 750 E. Adams Street, Syracuse, New York. - **Affiliation:** Norton College of Medicine at State University of New York Upstate Medical University. - **Key Features:** Level I trauma center, emergency department, pediatric intensive care unit, and comprehensive clinical departments.
Who should I call to ask about financial aid or insurance network?
For financial assistance at State University of New York Upstate Medical University hospital, contact the Financial Assistance department at 315-464-5026. For insurance inquiries, reach out to the Billing department at 315-464-4320 or 1-800-766-1539.
What insurance does State University of New York Upstate Medical University accept?
**SUNY Upstate Medical University Insurance and Health Services Overview** - SUNY Upstate Medical University mandates health insurance for all students, requiring proof of insurance during their annual health assessment. The Annual Student Health Fee facilitates access to the Student Health Office, with external medical services needing to be covered by the student's insurance. - University Hospital accepts a comprehensive list of insurance plans, including but not limited to ADAP Plus, Aetna, CIGNA, Fidelis Care, Medicaid, Medicare, and United Health Care. A detailed list is available for patients and includes specific programs for HIV+ patients through Inclusive Health Services. - SUNY Upstate employees benefit from a competitive package that includes health, dental, and vision insurance, an employee assistance program, retirement plans, and leave accruals. For details on specific benefits, employees are advised to contact the Human Resources Benefits Office.
What awards or recognition has State University of New York Upstate Medical University received?
The State University of New York Upstate Medical University hospital, located in Syracuse, New York, is renowned for its exceptional care. It has seen a significant 11% growth in research expenditures in the last fiscal year, nearing a total of $40M.